Miconazole extended-release - Vectans Pharma

Drug Profile

Miconazole extended-release - Vectans Pharma

Alternative Names: BA-001; Loramyc; Miconazole extended-release - Onxeo; Miconazole Lauriad 50mg Bioadhesive Extended-Release Buccal Tablets; Miconazole Lauriad Bioadhesive Buccal Tablets; Miconazole Lauriad®; Oravig; Sitamic; SO-1105

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioAlliance Pharma
  • Developer SciClone Pharmaceuticals; Sosei; Vectans Pharma
  • Class Antifungals; Imidazoles; Small molecules
  • Mechanism of Action Cell membrane modulators; Cholesterol synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Oropharyngeal candidiasis

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Oropharyngeal candidiasis in China (Buccal, Controlled release)
  • 31 Jul 2017 Vectans Pharma acquires Miconazole extended release from Onxeo
  • 28 Feb 2017 Preregistration for Oropharyngeal candidiasis in Japan (Buccal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top